Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. CME Group (CME - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Finance sector should help us answer this question.
CME Group is a member of the Finance sector. This group includes 866 individual stocks and currently holds a Zacks Sector Rank of #7. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. CME is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for CME's full-year earnings has moved 0.08% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the most recent data, CME has returned 30.33% so far this year. Meanwhile, stocks in the Finance group have lost about 9.81% on average. As we can see, CME Group is performing better than its sector in the calendar year.
Breaking things down more, CME is a member of the Securities and Exchanges industry, which includes 6 individual companies and currently sits at #10 in the Zacks Industry Rank. On average, this group has gained an average of 22.42% so far this year, meaning that CME is performing better in terms of year-to-date returns.
Going forward, investors interested in Finance stocks should continue to pay close attention to CME as it looks to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. CME Group (CME - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Finance sector should help us answer this question.
CME Group is a member of the Finance sector. This group includes 866 individual stocks and currently holds a Zacks Sector Rank of #7. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. CME is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for CME's full-year earnings has moved 0.08% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the most recent data, CME has returned 30.33% so far this year. Meanwhile, stocks in the Finance group have lost about 9.81% on average. As we can see, CME Group is performing better than its sector in the calendar year.
Breaking things down more, CME is a member of the Securities and Exchanges industry, which includes 6 individual companies and currently sits at #10 in the Zacks Industry Rank. On average, this group has gained an average of 22.42% so far this year, meaning that CME is performing better in terms of year-to-date returns.
Going forward, investors interested in Finance stocks should continue to pay close attention to CME as it looks to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CME - FREE